Navigation Links
Cota Healthcare Announces Major Multi-Year Collaboration With Global Pharmaceutical Leader To Advance Innovative Therapies For Breast Cancer Patients
Date:3/27/2017

NEW YORK, March 27, 2017 /PRNewswire/ -- Cota Healthcare, the leading data and technology platform for value-based precision medicine, today announced the signing of a major, multi-year collaboration with Novartis Pharmaceuticals Corporation to help improve clinical and cost outcomes for breast cancer patients.

As part of this agreement, which expands significantly on the previous announced collaboration entered into January 2016, teams from across Novartis Pharmaceuticals Corporation will leverage Cota's research-grade, real-world evidence, web-based analysis and visualization tools, and be supported by Cota's medical, data science, and technology experts. Utilizing the real-world evidence and technology platform supplied by Cota is expected to enable Novartis Pharmaceuticals Corporation to accelerate clinical development of new therapies for breast cancer and identify which patients will benefit most.

"Data and insight that comes directly from patient records - real-world evidence - is transforming how pharmaceutical and life science companies develop more precise, targeted therapies," said John Hervey, CEO of Cota. "Novartis has been an incredible collaborator over the last several years in adopting Cota's real-world evidence solutions to advance our shared goal of quantifiably improving and extending patient lives."

Cota's platform is powered by the patented Cota Nodal Address™ (CNA) system, a digital classification methodology that stratifies patients based on all the personal and clinical factors that matter to the individual. Each patient with the same CNA can be considered medically identical, and thus should have similar treatments and outcomes.

"We're excited about helping Novartis get deep insight into how patients are getting treatment in practice and connecting the dots all the way from patient to doctor to researcher," said Dr. Andrew Pecora, Founder & Executive Chairman of Cota. "Analyzing this data using CNAs is a critical factor in enabling healthcare companies to develop and target therapies that increase outcomes and lower the total cost of care."

About Cota Healthcare: 
Cota Healthcare is a technology platform that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. It is powered by the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. The CNA is the first and only system that precisely categorizes patient factors, their diseases and intended therapies, enabling precision medicine at scale.

Cota's technology enriches raw medical records to create research-grade data, and joins it with a suite of analysis, visualization, and management tools. This enables providers, payers, and life sciences companies to analyze, report on, and research outcomes, costs, treatments, and quality at any granularity and stage of the patient journey. The result is a constantly improving system that merges technology and science to help improve the lives of patients everywhere.

Press Contact: Matthew Levin 
Email: press@cotahealthcare.com
Phone: +1 (646) 543-2682

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cota-healthcare-announces-major-multi-year-collaboration-with-global-pharmaceutical-leader-to-advance-innovative-therapies-for-breast-cancer-patients-300429500.html


'/>"/>
SOURCE Cota Healthcare
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference on April 4th
2. Report: N.J. Hospitals Reduced Healthcare Costs by $641 Million Through Quality Improvement Initiative
3. Cantel Medical to Present at the 16th Annual Needham & Company Healthcare Conference
4. Frost & Sullivan Applauds GE Healthcares Visionary Innovation Strategy in Providing End-to-End Cardiac Diagnostic Solutions Globally
5. Teligent, Inc. To Present At Oppenheimer 27th Annual Healthcare Conference On March 22, 2017
6. Healthcare Stocks on Investors Radar -- Depomed, Novartis AG, TherapeuticsMD, and Tonix Pharma
7. Intec Pharma to Participate in the Oppenheimer 27th Annual Healthcare Conference
8. Omron Healthcare Agrees on Equity Investment and Expansion of Business Partnership with AliveCor
9. Healthcare Stocks on Investors Radar -- Delcath Systems, Palatin Technologies, AMAG Pharma, and IDEXX Laboratories
10. PDL BioPharma to Present at the Oppenheimer 27th Annual Healthcare Conference
11. Roche Diagnostics recognizes Poplar Healthcare as Roche Molecular Center of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2019)... ... January 10, 2019 , ... Pelican BioThermal , ... rapidly expand under the leadership of Dominic Hyde, vice president of Credo™ on ... temperature controlled shipper rental program allowing organizations to choose the shipper application that ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... ... as a kind of partnership. The implicit terms of this partnership hold that ... and administer the most effective treatment to restore the patient to improved health. ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... announced today that Philips, the leading international health technology company, has taken a ... Additional investors include StartUp Health and NueCura Partners. , Babyscripts has spent the ...
Breaking Medicine Technology:
(Date:1/14/2019)... ... January 14, 2019 , ... After many months of preparation, the providers ... Phoenix, Arcadia Allergy & Asthma. This new allergy and asthma clinic is conveniently located ... one stop destination for any immunological and respiratory medical care needs. , In the ...
(Date:1/14/2019)... ... January 15, 2019 , ... Early bird pricing for Medical Device ... management is just plain hard, complicated, conflicted, confusing. And it is getting even more ... are not intended as “major”, the new standard adds new definitions, changes the clause ...
(Date:1/14/2019)... ... ... Reviewed & Approved Living Well Providers of 2019. , Acupuncture, Dr. Wai ... - Maplewood , Dr. Joanna Jodar - Somerset , Dr. Barbara Knoll - ... Pleasant , Dr. Robert J. Reinhardt - Pequannock , Dr. Sylvester Rich - ...
(Date:1/13/2019)... (PRWEB) , ... January 12, 2019 , ... ... Professionals Committee (YPC) in conjunction with Temple University hosted a continuing education (CEU) ... and Mentees. The event aimed to create a series of talks to ...
(Date:1/11/2019)... MINNEAPOLIS (PRWEB) , ... January 11, 2019 , ... ... announced the three finalist teams in its “Next Generation Captive Insurance Solutions for ... by Strategic Risk Solutions. , The three finalist teams are: , ...
Breaking Medicine News(10 mins):